Curriculum Vitae:

PhD. Independent Researcher at CONICET.

Laboratory of Immuno-Oncology-IMEX-CONICET-National Academy of Medicine.

Professor at the Faculty of Medicine University of Buenos Aires (UBA) and at the Argentine Society of Hematology (SAH). Buenos Aires, Argentina

Curriculum Vitae:

Is a physician-scientist who is Head of the Karches Center for Oncology Research in The Feinstein Institutes for Medical Research and is Professor of Molecular Medicine and of Medicine in the Zucker School of Medicine at Hofstra/Northwell. The research interests of the Chiorazzi team revolve around understanding the activation and maturation of B lymphocytes in health and disease, especially in patients with chronic lymphocytic leukemia (CLL). Over the years, the Chiorazzi team contributed impactful information about the immunobiology of CLL cells. The group’s collective works led to Dr. Chiorazzi receiving the Binet-Rai medal from the International Workshops on CLL.

Curriculum Vitae:

Dr. Palacios is an Assistant Professor at the Institut Pasteur Montevideo, Uruguay, specializing in cancer immunology. She completed her Ph.D. focusing on chronic lymphocytic leukemia (CLL) under the mentorship of Prof. Dighiero and Dr. Oppezzo at the Institut Pasteur Montevideo. Following her Ph.D., she pursued postdoctoral research with Prof. Chiorazzi, MD, and Prof. Rai, MD, at The Feinstein Institutes for Medical Research in the United States, where she investigated the intraclonal complexity of B cells and its impact on the progression of CLL. In 2021, Dr. Palacios returned to Uruguay as an Assistant Professor at the Institut Pasteur Montevideo. Her research interests lie in translational medicine, with a particular focus on discovering new therapeutic targets and treatments.

Curriculum Vitae:

Martina Seiffert is a group leader at the German Cancer Research Center in Heidelberg. She is interested in immune modulatory mechanisms in the tumor microenvironment, with a focus on chronic lymphocytic leukemia. Using innovative single-cell omics approaches and functional studies with primary cell culture and mouse models, her team deciphers mechanisms of immune suppression and T-cell dysfunction and develops novel immunotherapies.